FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cefixime from Lupin Pharmaceuticals, Inc. to modify/extend its labeling and/or approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Gonorrhea
• Otitis Media
• Pharyngitis
• Pneumonia
• Sinusitis
• Tonsillitis
• Urinary Tract Infection

Drugs mentioned

• CEFIXIME (cefixime)

Snippet

SUPPL AP for CEFIXIME (CEFIXIME)